Testing effectiveness (Phase 2)Study completedNCT00031993
What this trial is testing
Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Who this might be right for
Cervical Squamous Cell CarcinomaRecurrent Cervical Cancer
National Cancer Institute (NCI) 51